Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status

Personalised medicine targeted to specific biomarkers such as BRAF and c-Kit has radically improved the success of melanoma therapy. More recently, further advances have been made using therapies targeting the immune response. In particular, therapies targeting the PD-1/PD-L1 or CTLA-4 axes alone or...

Descripción completa

Detalles Bibliográficos
Autores principales: Po, Joseph W., Ma, Yafeng, Balakrishna, Bavanthi, Brungs, Daniel, Azimi, Farhad, de Souza, Paul, Becker, Therese M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368301/
https://www.ncbi.nlm.nih.gov/pubmed/30735560
http://dx.doi.org/10.1371/journal.pone.0211866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368301/
https://www.ncbi.nlm.nih.gov/pubmed/30735560
http://dx.doi.org/10.1371/journal.pone.0211866

Ejemplares similares